Xanthosine

CAS No. 146-80-5

Xanthosine( Xanthosine | NSC 18930 | NSC-18930 )

Catalog No. M18039 CAS No. 146-80-5

Xanthosine is produced by guanine-free mutants of bacteria e. g. Bacillus subtilis, Aerobacter aerogenes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 38 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Xanthosine
  • Note
    Research use only, not for human use.
  • Brief Description
    Xanthosine is produced by guanine-free mutants of bacteria e. g. Bacillus subtilis, Aerobacter aerogenes.
  • Description
    Xanthosine treatment has been demonstrated to promote expansion of putative mammary stem cells. Xanthosine treatment also increased the proliferation rate of bovine MEC in vitro
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Xanthosine | NSC 18930 | NSC-18930
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    146-80-5
  • Formula Weight
    284.22
  • Molecular Formula
    C10H12N4O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 33.33 mg/mL 117.26 mM;
  • SMILES
    C1=NC2=C(N1C3C(C(C(O3)CO)O)O)NC(=O)NC2=O
  • Chemical Name
    9-beta-D-Ribofuranosylxanthine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Basibrol

    2,2,2-Tribromoethanol is white crystal or powder, sensitive to light and air.

  • 4-Hydroxy-L-phenylgl...

    4-Hydroxy-L-(+)-2-phenylglycine is a carnitine palmitoyltransferase-1 inhibitor. 4-Hydroxy-L-(+)-2-phenylglycine improves whole-body glucose tolerance and insulin sensitivity in high-fat diet-induced obese mouse with insulin resistance.

  • lorvotuzumab

    Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1) and can be used to synthesize the antibody-drug conjugate Lorvotuzumab mertansine.